Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cell intrinsic role of NF-κB-inducing kinase in regulating T cell-mediated immune and autoimmune responses.
[Neuromyelitis optica.]
The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial.
FDA Approves First Drug for Lou Gehrig's Disease
Selective depression of low-release probability excitatory synapses by sodium channel blockers.
Review: the role of vitamin D in nervous system health and disease.
Evaluation of the effectiveness of home based or hospital based calisthenic exercises in patients with multiple sclerosis.
Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
Cognitive Impairment in Multiple Sclerosis.
Biologically plausible and evidence-based risk intervals in immunization safety research.
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
How Natalizumab Binds and Antagonizes α4 Integrins.
The Impact of Social Media on Dissemination and Implementation of Clinical Practice Guidelines: A Longitudinal Observational Study.
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis.
Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.
Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils.
Placebo Cohorts in Phase-3 MS Treatment Trials - Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data.
Proteomic analysis of the anti-inflammatory action of minocycline.
Restless leg syndrome in different types of demyelinating neuropathies: a single-center pilot study.
MR Imaging in Multiple Sclerosis: The Accuracy of 3D Double Inversion Recovery at 3 Tesla and the Potential for Single Sequence Imaging.
A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
Secukinumab: first global approval.
Health-related quality of life in partners of persons with MS: a longitudinal 10-year perspective.
The relationship between upper leg muscle strength and walking capacity in persons with multiple sclerosis.

Pages